Deerfield Management Company LP Series C

Deerfield Management Company LP Series C, una sociedad limitada con sede en Delaware, opera con 125 empleados, de los cuales 96 son asesores, y su base de clientes sigue siendo desconocida. Fue autorizada por última vez por la SEC el 30 de marzo de 2012, y su estado de registro aparece como "aprobado".

• DAVID JUSTUS CLARK

  GENERAL COUNSEL posee menos de 5%

• FLYNN MANAGEMENT LLC

  GENERAL PARTNER posee 75% o más

• JAMES EDWARD FLYNN

  PRESIDENT posee menos de 5%

• JONATHAN DAVID ISLER

  CHIEF FINANCIAL OFFICER posee menos de 5%

• KAREN ARNONE NOY

  CHIEF ADMINISTRATIVE OFFICER posee menos de 5%

• MARIAN LYIA BRANCACCIO

  CHIEF COMPLIANCE OFFICER posee menos de 5%

• JAMES EDWARD FLYNN

  SOLE MEMBER posee 75% o más

• GOLDMAN SACHS & CO. LLC
  Estados Unidos
• MORGAN STANLEY & CO. LLC
  Estados Unidos
• NATIONAL FINANCIAL SERVICES LLC
  Estados Unidos

• Alternative Capital Advisers LLC
• Msress III Manager LLC
• Donald Smith LP
• ARCH Global Advisors LLC
• GS Investment Strategies LLC
• AJF Financial Services Inc
• Dwight Securities Management LLC
• Hudson BAY Capital Management LP
• RP Management LLC
• Stabilis Capital Management LP

• Deerfield Management Company's Q3 2022 vs. Q4 2022 13F Holdings Comparison: Which Companies Experienced the Most Significant Changes?

• HORIZON THERAPEUTICS PLC $155,491k
• HORIZON PHARMA INVESTMENT LTD $150,514k
• MYLAN N V $142,121k
• ORCHARD THERAPEUTICS PLC $124,841k
• NEVRO CORP $120,607k
• Homology Medicines $112,730k
• AERIE PHARMACEUTICALS INC $89,625k
• Intersect ENT Inc. $70,761k
• IMMUNOMEDICS INC $69,147k
• Acceleron Pharma Inc $53,617k